KAPA Kairos Pharma, Ltd. · XASE
0.31 -13.1% as of Jul 22, 14:55 ET
What's happening Live detector signal Generated 17:33 ET
Share structurereference + latest snapshot
Free float
13.4M
2026-03-31
Shares out
21.4M
latest detail
Market cap
$7.7M
ref price
Short interest
1.2%
2026-06-30
Float rotation
2.09×
latest signal
20d dollar vol
$1.7M
baseline
Filings and news
2026-07-22 14:55 ETSignalKairos Pharma, Ltd is down 13.1%, at 0.31, on $8.7M traded, 6.3× 20-day volume, 2.09× float rotation. Score 113. Primary driver: 2.1x float rotation.
2026-07-228-KItem 1.01 — Entry into a material definitive agreement; Item 8.01 — Other events +1 more SEC
2026-07-158-KItem 8.01 — Other events; Item 9.01 — Financial statements and exhibits SEC
2026-06-308-KCurrent report filed with SEC. SEC
2026-06-048-KItem 8.01 — Other events; Item 9.01 — Financial statements and exhibits SEC
2026-05-22DEF 14AProxy statement SEC
2026-05-188-KItem 8.01 — Other events; Item 9.01 — Financial statements and exhibits SEC
2026-04-28 23:10 ETLegalKAPA Investors Have Opportunity to Join Kairos Pharma, Ltd. Fraud Investigation with the Schall Law Firm News
2024-09-17 16:29 ETOfferingKairos Pharma Closing of $6.2 Million Initial Public Offering News
Latest detector signal113 Extreme
Move
-13.1%
Dollar volume
$8.7M
Rel volume
6.3×
Float rotation
2.09×

Primary driver: 2.1x float rotation

gap -13.1%$8.7M traded6.3x 20d volume2.1x float rotationmicrocap